Axovant Sciences Ltd. (NYSE: AXON) announced that the company has received Fast Track designation for its Investigational New Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE